BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1433879)

  • 1. [Neuromuscular blocking effect of ORG9426, a new non-depolarizing muscle relaxant, and its recovery with various antagonists in vitro].
    Okamoto T; Aoki T; Fukushima K; Yoneda I; Satoh T; Nagashima H
    Masui; 1992 Sep; 41(9):1467-73. PubMed ID: 1433879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis attenuates the intensity of the neuromuscular blocking effect of d-tubocurarine and the antagonistic actions of neostigmine and edrophonium accompanying depression of muscle contractility of the diaphragm.
    Narimatsu E; Nakayama Y; Sumita S; Iwasaki H; Fujimura N; Satoh K; Namiki A
    Acta Anaesthesiol Scand; 1999 Feb; 43(2):196-201. PubMed ID: 10027028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to depolarization and nondepolarizing neuromuscular blocking agents in young rat hemidiaphragms.
    Fortier LP; Robitaille R; Donati F
    Anesthesiology; 2001 Aug; 95(2):478-84. PubMed ID: 11506123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects.
    Vizi ES; Tuba Z; Mahó S; Foldes FF; Nagano O; Dóda M; Takagi S; Chaudhry IA; Saubermann AJ; Nagashima H
    Acta Anaesthesiol Scand; 2003 Mar; 47(3):291-300. PubMed ID: 12648195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two new short-acting non-depolarizing neuromuscular blocking agents.
    Copp FC; Coker GG; Green AF; Hughes R; Nimmo-Smith RH
    Experientia; 1972 Jan; 28(1):47-8. PubMed ID: 4259013
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between ORG9426 and other non-depolarizing neuromuscular blocking agents in rats in vivo.
    Watanabe K
    J Anesth; 1992 Jul; 6(3):277-83. PubMed ID: 15278537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-curare effect of plasma from patients with thermal injury.
    Storella RJ; Martyn JA; Bierkamper GG
    Life Sci; 1988; 43(1):35-40. PubMed ID: 2968490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of respiratory sparing effect between pancuronium and three new nondepolarizing muscle relaxants in rats.
    Kaneko M; Hua L
    J Anesth; 1998 Dec; 12(4):185-188. PubMed ID: 28921314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neostigmine, edrophonium, 4-aminopyridine and their combinations.
    Treffers R; Frankhuyzen AL; Booij LH
    Acta Anaesthesiol Belg; 1988; 39(1):55-8. PubMed ID: 2835880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of CO2-induced acid-base changes on the potencies of muscle relaxants and antagonism of neuromuscular block by neostigmine in rat in vitro.
    Aziz L; Ono K; Ohta Y; Morita K; Hirakawa M
    Anesth Analg; 1994 Feb; 78(2):322-7. PubMed ID: 8311285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pralidoxime inhibits paraoxon-induced depression of rocuronium-neuromuscular block in a time-dependent fashion.
    Narimatsu E; Niiya T; Takahashi K; Yamauchi M; Yamakage M
    Am J Emerg Med; 2012 Jul; 30(6):901-7. PubMed ID: 21871755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking profile of the vecuronium analogue, Org-9487, in the rat isolated hemidiaphragm preparation.
    Prior C; Tian L; el Mallah AI; Young L; Ward JM
    Br J Pharmacol; 1995 Dec; 116(7):3049-55. PubMed ID: 8680742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone, a phosphodiesterase III inhibitor, antagonizes the neuromuscular blocking effect of a non-depolarizing muscle relaxant in vitro.
    Narimatsu E; Nakayama Y; Aimono M; Fujimura N; Iwasaki H; Namiki A
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):219-28. PubMed ID: 10634314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of phenytoin on rocuronium-induced neuromuscular block in the rat phrenic nerve-hemidiaphragm preparation.
    Kim JU; Lee YK; Lee YM; Yang HO; Han SM; Yang HS
    J Neurosurg Anesthesiol; 2005 Jul; 17(3):149-52. PubMed ID: 16037736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro neuromuscular effects of valproic acid.
    Nguyen A; Ramzan I
    Br J Anaesth; 1997 Feb; 78(2):197-200. PubMed ID: 9068341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
    Davis L; Jayarajah MJ; Toner CC; Flynn PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro.
    Sekerci S; Tulunay M
    Anaesthesia; 1996 Feb; 51(2):140-4. PubMed ID: 8779369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro potency and mode of action of ANQ9040: a novel fast acting muscle relaxant.
    Lees G; Munday IT; Edwards MD; Jones RM
    Br J Pharmacol; 1994 Oct; 113(2):642-8. PubMed ID: 7834218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing potencies of muscle relaxants on rat and guinea-pig phrenic nerve diaphragm preparations.
    Bradshaw EG; Harper NJ; Pleuvry BJ; Modla CY
    J Pharm Pharmacol; 1986 Aug; 38(8):623-4. PubMed ID: 2876083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.